Participation of autophagy in the cytotoxicity against breast cancer cells by cisplatin.

Breast cancer is one of the most common cancers affecting women worldwide. Conventional chemotherapy is still one of the major approaches to the treatment of breast cancer. Autophagy, also termed as type II programmed cell death (PCD), exhibits either a protumorigenic or antitumorigenic function. In the present study, we investigated whether autophagy could be involved in the effect of chemotherapy against breast cancer. Epirubicin, docetaxel, methotrexate, cyclophosphamide, fluorouracil (5-FU) and cisplatin were applied in the present investigation. All of these chemotherapeutics presented cytotoxicity against breast cancer cells. DsRed-LC3 reporter assay revealed that only docetaxel and cisplatin induced autophagy. Autophagy inhibitor 3-methyladenine (3-MA) strengthened the cytotoxicity of docetaxel, yet impaired the cytotoxicity of cisplatin, suggesting that docetaxel stimulates protumorigenic autophagy, while cisplatin-induced autophagy could be antitumorigenic. Real-time PCR revealed that cisplatin upregulated multiple autophagy-related genes, including AMBRA1, ATG3, ATG4C, ATG4D, ATG5, ATG7, ATG13, ATG14, ATG16L2, Beclin1, DRAM1, GABARAP, GABARAPL1, GABARAPL2, HDAC6, IRGM, MAP1LC3B and ULK1, indicating that cisplatin induced autophagy through a multiple mechanism involved manner.

[1]  N. Weerapreeyakul,et al.  Melatonin potentiates cisplatin‐induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells , 2015, Cell proliferation.

[2]  L. Kiew,et al.  Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy , 2014, Cancer Cell International.

[3]  T. Ueno,et al.  In Vitro Assays of Lipidation of Mammalian Atg8 Homologs , 2014, Current protocols in cell biology.

[4]  Wei Li,et al.  Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells , 2014, Anti-cancer drugs.

[5]  Kuen-Feng Chen,et al.  Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation* , 2013, The Journal of Biological Chemistry.

[6]  Yan Cheng,et al.  Beclin-1: autophagic regulator and therapeutic target in cancer. , 2013, The international journal of biochemistry & cell biology.

[7]  Gang Wu,et al.  Knockdown of autophagy-related gene BECLIN1 promotes cell growth and inhibits apoptosis in the A549 human lung cancer cell line. , 2013, Molecular medicine reports.

[8]  J. Carew,et al.  Autophagy as a target for cancer therapy: new developments , 2012, Cancer management and research.

[9]  S. Andò,et al.  CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis , 2012, Cell cycle.

[10]  Xiaoping Li,et al.  Nifedipine induced autophagy through Beclin1 and mTOR pathway in endometrial carcinoma cells. , 2012, Chinese medical journal.

[11]  F. Sinicrope,et al.  The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.

[12]  J. Debnath,et al.  The Multifaceted Roles of Autophagy in Tumors—Implications for Breast Cancer , 2011, Journal of Mammary Gland Biology and Neoplasia.

[13]  D. Sabatini,et al.  Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. , 2011, Cancer cell.

[14]  Fang Lin,et al.  Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis. , 2011, World journal of gastroenterology.

[15]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[16]  D. Rubinsztein,et al.  Regulation of mammalian autophagy in physiology and pathophysiology. , 2010, Physiological reviews.

[17]  M. Gariboldi,et al.  Chromosome band 17q21 in breast cancer: Significant association between beclin 1 loss and HER2/NEU amplification , 2010, Genes, chromosomes & cancer.

[18]  J. Debnath,et al.  Autophagy and Tumorigenesis , 2010, Seminars in Immunopathology.

[19]  D. Hailey,et al.  Autophagy termination and lysosome reformation regulated by mTOR , 2010, Nature.

[20]  Y. Miao,et al.  Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress‐independent growth inhibition of pancreatic cancer cells through G2/M cell‐cycle arrest and apoptosis , 2010, Cancer science.

[21]  Yongqiang Chen,et al.  Methods for detecting autophagy and determining autophagy-induced cell death. , 2010, Canadian journal of physiology and pharmacology.

[22]  Daniel J Klionsky,et al.  Mammalian autophagy: core molecular machinery and signaling regulation. , 2010, Current opinion in cell biology.

[23]  C. Jung,et al.  ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. , 2009, Molecular biology of the cell.

[24]  S. Pattingre,et al.  Regulation of macroautophagy by mTOR and Beclin 1 complexes. , 2008, Biochimie.

[25]  Kevin M. Ryan,et al.  DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis , 2006, Cell.

[26]  Kevin Bray,et al.  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. , 2006, Cancer cell.

[27]  R. Carlson,et al.  Update: NCCN breast cancer Clinical Practice Guidelines. , 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

[28]  Govind Bhagat,et al.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.

[29]  A. Sasco,et al.  Breast cancer: occurrence, risk factors and hormone metabolism , 2003, Expert review of anticancer therapy.